Source: Stem cell research & therapy. Unidade: FM
Subjects: HEMODINÂMICA, CÉLULAS ESTROMAIS, HIPERTENSÃO PULMONAR, PULMÃO
ABNT
MENDONÇA, Lucas de et al. Mesenchymal stromal cell therapy reduces lung inflammation and vascular remodeling and improves hemodynamics in experimental pulmonary arterial hypertension. Stem cell research & therapy, v. 08, 2017Tradução . . Disponível em: https://doi.org/10.1186/s13287-017-0669-0. Acesso em: 26 ago. 2024.APA
Mendonça, L. de, Felix, N. S., Blanco, N. G., Silva, J. S. D., Ferreira, T. P., Abreu, S. C., et al. (2017). Mesenchymal stromal cell therapy reduces lung inflammation and vascular remodeling and improves hemodynamics in experimental pulmonary arterial hypertension. Stem cell research & therapy, 08. doi:10.1186/s13287-017-0669-0NLM
Mendonça L de, Felix NS, Blanco NG, Silva JSD, Ferreira TP, Abreu SC, Cruz FF, Rocha N, Silva PM, Martins V, Capelozzi VL, Zapata-Sudo G, Rocco PRM, Silva PL. Mesenchymal stromal cell therapy reduces lung inflammation and vascular remodeling and improves hemodynamics in experimental pulmonary arterial hypertension [Internet]. Stem cell research & therapy. 2017 ; 08[citado 2024 ago. 26 ] Available from: https://doi.org/10.1186/s13287-017-0669-0Vancouver
Mendonça L de, Felix NS, Blanco NG, Silva JSD, Ferreira TP, Abreu SC, Cruz FF, Rocha N, Silva PM, Martins V, Capelozzi VL, Zapata-Sudo G, Rocco PRM, Silva PL. Mesenchymal stromal cell therapy reduces lung inflammation and vascular remodeling and improves hemodynamics in experimental pulmonary arterial hypertension [Internet]. Stem cell research & therapy. 2017 ; 08[citado 2024 ago. 26 ] Available from: https://doi.org/10.1186/s13287-017-0669-0